HCA Healthcare EPS Outlook Up $0.36 to $30.01, 6.4% Growth Projected
HCA Healthcare’s stock maintains a #3 Hold rating with A-grade Growth and VGM scores, forecasting 6.4% year-over-year earnings growth. The consensus EPS estimate has been raised by $0.36 to $30.01, and the company operates 190 hospitals and 2,500 ambulatory sites across 19 U.S. states and the U.K.
1. EPS Estimate Revision and Growth Outlook
Analysts raised the fiscal 2026 consensus EPS estimate by $0.36 to $30.01, driven by revisions from six analysts in the past 60 days. This uplift supports a projected 6.4% year-over-year earnings increase and reflects an average historical earnings surprise of 13.6%.
2. Style Scores and Stock Rating
The stock maintains a #3 Hold rating, while its Growth and VGM Style Scores are graded A, signaling strong growth prospects and combined momentum/value attributes. These ratings suggest a favorable risk-reward profile for investors seeking both growth consistency and market momentum.
3. Operational Footprint
HCA Healthcare operates 190 acute care hospitals and approximately 2,500 ambulatory sites, including surgery centers, freestanding emergency rooms, urgent care clinics and physician practices, across 19 U.S. states and the United Kingdom. This extensive network underpins its revenue diversification and capacity for sustained growth.